The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice.
Moreira GA, Caetano MMM, do Vale JA, de Paiva JC, Gonçalves VHS, Almeida AA, Silva LVG, Martim FRG, de Andrade Barros MV, Guimarães GR, de Oliveira Santos L, de Souza APM, Machado-Neves M, Teixeira RR, Silva-Júnior A, Fietto JLR, Boroni M, de Oliveira LL, Bressan GC.
Moreira GA, et al. Among authors: teixeira rr.
Biochem Pharmacol. 2022 Sep;203:115161. doi: 10.1016/j.bcp.2022.115161. Epub 2022 Jul 2.
Biochem Pharmacol. 2022.
PMID: 35787994
Free article.